GSA CAPITAL PARTNERS LLP - DICE THERAPEUTICS INC ownership

DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 87 filers reported holding DICE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.37 and the average weighting 1.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$297
-24.6%
6,402
-49.3%
0.03%
-38.8%
Q4 2022$394
-99.8%
12,637
-5.2%
0.05%
+58.1%
Q2 2022$207,00013,3250.03%
Other shareholders
DICE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Northpond Ventures, LLC 3,292,871$83,343,00029.17%
Sands Capital Ventures, LLC 3,148,970$79,700,00011.81%
OUP Management Co., LLC 536,693$13,584,0006.12%
New Leaf Venture Partners, L.L.C. 556,693$14,090,0005.10%
Logos Global Management LP 1,664,251$42,122,0004.34%
Asymmetry Capital Management, L.P. 185,201$4,687,0002.49%
Deep Track Capital, LP 1,341,004$33,941,0002.40%
RA Capital Management 5,208,911$131,838,0002.32%
Soleus Capital Management, L.P. 810,940$20,525,0002.06%
Miller Investment Management, LP 180,901$4,579,0000.66%
View complete list of DICE THERAPEUTICS INC shareholders